Form D · Biotechnology
Automera US Inc.
Seattle, WA · CIK 0001992812
Offering snapshot reported Aug 7, 2026 · SEC filing
- Reported sold
- $1M Offering amount: $7M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 7, 2026 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
| Oct 17, 2024 | Amendment | $12,199,998 | $5,249,998vs Sep 27, 2023 | 12 | SEC filing |
| Sep 27, 2023 | Initial | $6,950,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593469
Source: Form D, filed Aug 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean Cassidy | Director |
| Yu Chieh Alice Chen | Director |
| Wen Qi Ho | Director |
| Ian Howes | Executive, Promoter |
| Mitchell Hymowitz | Executive |
| Thong Le | Director, Executive, Promoter |
| Kendall Mohler | Executive |
| Suzanne Rettenmier | Executive |
| Benjamin Zian Loong Wang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2815 Eastlake Ave E #300
Seattle, WA, 98102
Phone: 206-957-7300
Seattle, WA, 98102
Phone: 206-957-7300